Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9


The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.

Sun X, Hirota SA.

Mol Immunol. 2015 Feb;63(2):193-202. doi: 10.1016/j.molimm.2014.09.005. Epub 2014 Sep 18. Review.


Engineered single-domain antibodies with high protease resistance and thermal stability.

Hussack G, Hirama T, Ding W, Mackenzie R, Tanha J.

PLoS One. 2011;6(11):e28218. doi: 10.1371/journal.pone.0028218. Epub 2011 Nov 30.


The enterotoxicity of Clostridium difficile toxins.

Sun X, Savidge T, Feng H.

Toxins (Basel). 2010 Jul;2(7):1848-80. doi: 10.3390/toxins2071848. Epub 2010 Jul 14. Review.


The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge.

Dubberke ER, Haslam DB, Lanzas C, Bobo LD, Burnham CA, Gröhn YT, Tarr PI.

Zoonoses Public Health. 2011 Feb;58(1):4-20. doi: 10.1111/j.1863-2378.2010.01352.x. Epub 2010 Sep 24. Review.


Toxic megacolon associated Clostridium difficile colitis.

Sayedy L, Kothari D, Richards RJ.

World J Gastrointest Endosc. 2010 Aug 16;2(8):293-7. doi: 10.4253/wjge.v2.i8.293.


Clostridium difficile infection.

Heinlen L, Ballard JD.

Am J Med Sci. 2010 Sep;340(3):247-52. doi: 10.1097/MAJ.0b013e3181e939d8. Review.


Clostridium difficile associated infection, diarrhea and colitis.

Hookman P, Barkin JS.

World J Gastroenterol. 2009 Apr 7;15(13):1554-80. Review.


Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infection.

Baines SD, Freeman J, Wilcox MH.

Antimicrob Agents Chemother. 2009 May;53(5):2202-4. doi: 10.1128/AAC.01085-08. Epub 2009 Feb 17.

Supplemental Content

Support Center